HCPCS Level IIdrugActive
J0598
C-1 esterase, cinryze
BETOS: O1E
Effective: 2011-01-01
Description
Injection, c-1 esterase inhibitor (human), cinryze, 10 units
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cinryze
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
10 UNITS
Billing Units
50.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.